BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190416
DTEND;VALUE=DATE:20190418
DTSTAMP:20260514T214533
CREATED:20181005T132158Z
LAST-MODIFIED:20181005T132334Z
UID:17940-1555372800-1555545599@www.pharmajournalist.com
SUMMARY:17th annual eyeforpharma Philadelphia Conference
DESCRIPTION:Where pharma’s performance is built by patient value \nThe world’s greatest gathering of pharma’s value-designers \nEvery important industry player in one room\, evolving our antiquated model by embracing value-based care. That’s the vision for eyeforpharma Philadelphia\, the flagship event where pharma\, patients and payers co-design for outcomes. \nThere are dozens of events on digital\, on patient centricity\, on data\, on access\, on medical\, on commercial. Only one event brings all the key designers together so that we can address unmet need\, create solutions that cover the spectrum\, and end the age-old problems of misalignment. \nJoin us for pharma’s most influential meeting – as we write the blueprint for healthcare’s future. \nTo learn more about this event\, and to register online\, visit http://bit.ly/2O8ldd5
URL:https://www.pharmajournalist.com/event/17th-annual-eyeforpharma-philadelphia-conference/
LOCATION:Pennsylvania Convention Center\, 1101 Arch St\, Philadelphia\, PA\, 19107\, United States
ORGANIZER;CN="eyeforpharma":MAILTO:jbramwell@eyeforpharma.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190416
DTEND;VALUE=DATE:20190418
DTSTAMP:20260514T214533
CREATED:20190108T073610Z
LAST-MODIFIED:20190108T073610Z
UID:18942-1555372800-1555545599@www.pharmajournalist.com
SUMMARY:CAR-T Congress USA
DESCRIPTION:CAR-T therapy is set to revolutionize oncology pipelines and mark a new era for personalized medicine. With the recent approvals of Yescarta and Kymriah and the $11 billion acquisition of Kite\, the race is on to lead the commercialization of safe\, efficacious and accessible CAR-T therapy. \n \nThe fourth annual CAR-T congress USA provides a platform for emerging novel data in small scale clinical trials ran by the leading academic institutions\, including MD Anderson and the University of Pennsylvania. \nHear first-hand\, the emerging areas of research from new companies into single patient experiences\, as well as context around patient relapses and methods of toxicity management. \nJoin thought leaders from biotechs\, pharmaceutical companies and academia to address the challenges of CAR-T therapy including toxicity\, scalability and efficacy in both liquid and solid tumours. \nDiscover how CAR-T compares to standard treatments and advances in genome editing tools\, the new methods in allogeneic and autologous process development and the pre-clinical concepts that will pave the way for novel antigen discovery. \nBe part of the movement that engineers a strategy to reprogram the cancer treatments we know today. \nBook before January 25 to save up to $800.  To learn more about this event and to book online visit: www.car-tcongress.com/register
URL:https://www.pharmajournalist.com/event/car-t-congress-usa/
LOCATION:Hyatt Regency Boston Harbor\, 101 Harborside Drive\, Boston\, MA\, 02128\, United States
ORGANIZER;CN="Kisaco Research":MAILTO:events@kisacoresearch.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190416
DTEND;VALUE=DATE:20190419
DTSTAMP:20260514T214533
CREATED:20190220T073216Z
LAST-MODIFIED:20190220T073349Z
UID:19646-1555372800-1555631999@www.pharmajournalist.com
SUMMARY:Neuroimmunology Drug Development Summit (NIDD)
DESCRIPTION:Built with thought-leaders at Sanofi\, Eisai\, AbbVie and Denali\, the inaugural NIDD Summit will share the field’s cutting-edge scientific advances enabling you to translate your neuroimmunology research into a clinically effective therapeutic for neurological diseases. \n\nWith an emphasis on neurodegeneration\, chronic neuroinflammatory mechanisms will be explored whilst addressing your drug development challenges: \n\nDiscover robust biomarkers of neuroinflammation to enable successful translation and patient stratification\nNavigate preclinical model limitations to better predict clinical efficacy\nExplore the identification and validation of neuroimmunological targets and assess novel therapeutic approaches\n\nDon’t miss this opportunity to learn from 20+ industry expert speakers to effectively target neuroimmunological mechanisms and rapidly progress your research to the clinic. \nFor more information\, visit www.neuroimmunology-drugdevelopment.com
URL:https://www.pharmajournalist.com/event/neuroimmunology-drug-development-summit-nidd/
LOCATION:Hyatt Regency Boston  One Avenue de Lafayette\, Boston  Massachusetts\, United States\, 02111
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR